Incyte Corporation
INCY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $3 | $3 |
| % Growth | 14.8% | 8.9% | 13.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $4 | $3 | $3 | $3 |
| % Margin | 91.1% | 91.5% | 92.5% | 93.7% |
| R&D Expenses | $3 | $2 | $2 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $3 | $3 | $2 |
| Operating Income | $0 | $1 | $1 | $1 |
| % Margin | 1.9% | 17.6% | 17.7% | 21.3% |
| Other Income/Exp. Net | $0 | $0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | $0 | $1 | $0 | $1 |
| % Margin | 0.8% | 16.2% | 10% | 31.8% |
| EPS | 0.16 | 2.67 | 1.53 | 4.3 |
| % Growth | -94% | 74.5% | -64.4% | – |
| EPS Diluted | 0.15 | 2.65 | 1.52 | 4.27 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $1 | $1 | $1 |
| % Margin | 9.6% | 24.9% | 17.7% | 21.1% |